UnitedHealth Group Incorporated (UNH)
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Arrowstreet Capital Limited Partnership Has $1.17 Billion Stock Position in UnitedHealth Group Incorporated $UNH
Arrowstreet Capital Limited Partnership increased its stake in UnitedHealth Group Incorporated (NYSE: UNH) by 17.3% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,401,853 shares of the healthcare conglomerate's stock after buying an additional 502,474 shares during the
UnitedHealth Group Incorporated (UNH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
UnitedHealth Group Incorporated (UNH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
UnitedHealth Group (UNH) closed the most recent trading day at $285.25, moving +1.03% from the previous trading session.
U.S. senator Markwayne Mullin just made a super suspicious stock trade
Markwayne Mullin, American politician serving as Oklahoma's junior United States senator, has filed a new Periodic Transaction Report, revealing a rather suspicious joint stock purchase.
UNH Deploys AI in Optum Rx to Tackle Pharmacy Fraud and Cost Leakage
UnitedHealth rolls out AI in Optum Rx to flag pharmacy fraud, billing anomalies and medication risks, aiming to curb cost leakage and improve compliance.
Healthcare Jobs Drop, UnitedHealth Stock Slips: Opportunity or Risk?
UNH faces rising medical costs, regulatory probes and a healthcare hiring slump while shares keep falling, leaving investors weighing risk or opportunity.
Here's Why UnitedHealth Group (UNH) Fell More Than Broader Market
The latest trading day saw UnitedHealth Group (UNH) settling at $289.21, representing a -1.94% change from its previous close.
UnitedHealth: A Golden Buying Opportunity (Rating Upgrade)
UnitedHealth is upgraded to 'Buy' as pessimism appears overdone and shares trade near a strong $300 support with compelling valuation metrics. UNH's scale, AI-driven cost efficiencies, and exposure to an aging U.S. population position it for long-term EPS and revenue recovery despite near-term stagnation. The stock offers a 3% forward dividend yield with a low 53% payout ratio and a solid record of dividend growth, appealing to income investors.
Is The Bottom In For UNH Stock After Its Dramatic 23% Slide?
UnitedHealth (UNH) stock has dropped by 23.1% in under a month, from $356 on January 23, 2026 to $274 now, primarily due to a "perfect storm" of disappointing 2026 financial guidance and a major regulatory shock, with the Trump administration proposing essentially flat reimbursement rates for 2027 (an increase of only 0.09%), which was significantly lower than industry models.
UnitedHealthcare Under Pressure: Can UNH's Core Business Rebound?
UnitedHealth Group Incorporated's UNH health benefits arm, UnitedHealthcare, remains the company's primary revenue engine, yet profitability pressures continue to weigh on investor sentiment. Although the segment's revenues climbed 15.7% in 2025 to $344.9 billion, adjusted operating earnings fell sharply by 41.1% to $9.6 billion, reflecting reduced Medicare funding and persistently elevated medical cost trends.
The Zacks Analyst Blog UnitedHealth, Honeywell , Shopify and Optex Systems
UNH, HON and SHOP land fresh Zacks reports, spotlighting earnings beats, margin pressures and segment strength shaping their outlook.
